Mirae Asset Global ETFs Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.2M	Sell	394,629 -1,635	-0.4%	-$6.32K	﹤0.01%	1434
2025 Q4	$1.62M	Buy	396,264 +187,504	+90%	+$929K	﹤0.01%	1259
2025 Q3	$1.02M	Buy	208,760 +5,266	+3%	+$27.7K	﹤0.01%	1480
2025 Q2	$1.03M	Buy	203,494 +26,060	+15%	+$128K	﹤0.01%	1432
2025 Q1	$953K	Buy	177,434 +12,372	+7%	+$90.2K	﹤0.01%	1529
2024 Q4	$1.12M	Buy	165,062 +7,939	+5%	+$53.4K	﹤0.01%	1490
2024 Q3	$1.05M	Buy	157,123 +72,182	+85%	+$517K	﹤0.01%	1516
2024 Q2	$638K	Buy	+84,941	New	+$741K	﹤0.01%	1702

Other funds holding RXRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RXRX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Recursion Pharmaceuticals (RXRX) stake by 0.41% in Q1 2026, selling an estimated $6.32K and leaving 394,629 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

Mirae Asset Global ETFs Holdings first reported a position in RXRX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.62M in Q4 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

Mirae Asset Global ETFs Holdings held 394,629 shares of Recursion Pharmaceuticals worth $1.2M as of Q1 2026.
Mirae Asset Global ETFs Holdings sold 1,635 Recursion Pharmaceuticals shares in Q1 2026, an estimated $6.32K.
Recursion Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1434 holding.
Mirae Asset Global ETFs Holdings first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Recursion Pharmaceuticals position peaked at $1.62M in Q4 2025.
334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.